A Bioequivalence Study of Hetrombopag in Healthy Subjects

NCT05088655 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Sever Aplastic Anaemia

Interventions

DRUG: Hetrombopag Olamine Tablet

Sponsor

Jiangsu HengRui Medicine Co., Ltd.